Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NeuroCatch Reference Interval Database

NCT: NCT06677424 · TERMINATED

NCT IDNCT06677424
StatusTERMINATED
Start Date2024-08-05
Completion2026-06-30
SponsorHealthTech Connex Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to understand how the brain responds to sounds and words, and how this response varies between individuals. The purpose if this study is to develop data set comparing the results from one individual with those from other members (a reference interval database of NeuroCatch® Platform 2) and to quantify the expected distribution across sex and age. NeuroCatch® Platform 2, is a medical device approved by Health Canada. The plan is to enroll 810 participants, the study includes screening for eligibility and one brain scan. The study is conducted at the Centre for Neurology Studies in Surrey, BC or at its satellite sites ( if required).

Frequently Asked Questions

What is NeuroCatch Reference Interval Database?

NeuroCatch Reference Interval Database is a clinical trial registered under NCT06677424. Current status: TERMINATED.

What is the status of NCT06677424?

The current status of NCT06677424 (NeuroCatch Reference Interval Database) is: TERMINATED.

When did NeuroCatch Reference Interval Database start?

NeuroCatch Reference Interval Database started on 2024-08-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.